Concepedia

Roberto Carmagnani Pestana

RC

18

Publications

763

Citations

15

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Cannon

Hospital Israelita Albert Einstein

Rutgers Cancer Institute

Rutgers, The State University of New Jersey

Roberto Carmagnani Pestana is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and clinical trials.

ORCID

Top concepts

Publications per year

2013–2023

18

Publications

18

IL-6–Mediated Induction of Matrix Metalloproteinase-9 Is Modulated by JAK-Dependent IL-10 Expression in Macrophages

Poonam Kothari, Roberto Carmagnani Pestana, Rim Mesraoua et al. · The Journal of Immunology · 2013 · 133 citations · Full text

, , +19

Moving Beyond 3+3: The Future of Clinical Trial Design

Razelle Kurzrock, Chia‐Chi Lin, Tsung‐Che Wu et al. · American Society of Clinical Oncology Educational Book · 2021 · 102 citations · Full text

, , +17

Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA

Ahmed O. Kaseb, Nora Sánchez, Shiraj Sen et al. · Clinical Cancer Research · 2019 · 76 citations · Full text

Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma

Ahmed O. Kaseb, Luis M. Vence, Jorge Blando et al. · Cancer Immunology Research · 2019 · 67 citations · Full text

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases

Amanda Parkes, Carla L. Warneke, Katherine Clifton et al. · The Oncologist · 2018 · 65 citations · Full text

Rows per page

1–5 of 18